Should You Continue to Hold Hologic Stock Post Q4 Earnings? [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
The buyout price consists of $76 per share in cash plus a non-tradable contingent value right (CVR) worth up to $3 per share. Meanwhile, the company's fiscal 2025 fourth quarter results, released on Nov. 3, reflected solid progress toward returning to better top- and bottom-line growth. Revenue increased 6.2% to $1.05 billion, while adjusted earnings per share (EPS) of $1.13 climbed 11.9%. Performance was driven by the continued rebound of the Breast Health business and also supported by contributions from other segments. Given the pending transaction, management refrained from providing any guidance for fiscal 2026. Meanwhile, Hologic recently had a major regulatory win. Its Genius Digital Diagnostics System has achieved expanded CE marking in the European Union, now approved to image and review both cell and tissue specimens. Previously, it was CE marked specifically for cell analysis, mainly used in cervical cancer screening, among other applications, and also received FDA cleara
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Qiagen (NYSE:QGEN) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Qiagen (NYSE:QGEN) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025Business Wire
- QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share RepurchaseBusiness Wire
- QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutionsBusiness Wire
QGEN
Earnings
- 11/4/25 - Beat
QGEN
Sec Filings
- 11/12/25 - Form SCHEDULE
- 11/6/25 - Form 6-K
- 11/6/25 - Form 6-K
- QGEN's page on the SEC website